1. bookVolumen 70 (2020): Edición 1 (March 2020)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Sildenafil alters biogenic amines and increases oxidative damage in brain regions of insulin-hypoglycemic rats

Publicado en línea: 01 Nov 2019
Volumen & Edición: Volumen 70 (2020) - Edición 1 (March 2020)
Páginas: 121 - 127
Aceptado: 30 Mar 2019
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. A. V. Raveendran, E. C. Chacko and J. M. Pappachan, Non-pharmacological treatment options in the management of diabetes mellitus, Eur. Endocrinol.14 (2018) 31–39; https://doi.org/10.17925/EE.2018.14.2.3110.17925/EE.2018.14.2.31618292030349592Search in Google Scholar

2. A. Hussain, O. B. Latiwesh, F. Ali, M. Y. G. Younis and J. A. Alammari, Effects of body mass index, glycemic control, and hypoglycemic drugs on serum uric acid levels in type 2 diabetic patients, Cureus10 (2018) e3158; https://doi.org/10.7759/cureus.315810.7759/cureus.3158619356830349765Search in Google Scholar

3. G. T. Chen, B. B. Yang, J. H. Chen, Z. Zhang, L. L. Zhu, H. S. Jiang, W. Yu, Y. Chen and Y. T. Dai, Pancreatic kininogenase improves erectile function in streptozotocin-induced type 2 diabetic rats with erectile dysfunction, Asian J. Androl.20 (2018) 448–453; https://doi.org/10.4103/aja.aja_23_1810.4103/aja.aja_23_18611667529676291Search in Google Scholar

4. L. Chen, S. E. Staubli, M. P. Schneider, A. G. Kessels, S. Ivic, L. M. Bachmann and T. M. Kessler, Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis, Eur. Urol.68 (2015) 674–680; https://doi.org/10.1016/j.eururo.2015.03.03110.1016/j.eururo.2015.03.03125817916Search in Google Scholar

5. R. S. Calabrò, G. Polimeni and P. Bramanti, Current and future therapies of erectile dysfunction in neurological disorders, Rec. Pat. CNS Drug Discov.6 (2011) 48–64.10.2174/15748891179407908221073433Search in Google Scholar

6. S. J. Flora, Role of free radicals and antioxidants in health and disease, Cell. Mol. Biol.53 (2007) 1–2.Search in Google Scholar

7. J. T. Coyle and P. Puttfarcken, Oxidative stress, glutamate, and neurodegenerative disorders, Science262 (1993) 689–695.10.1126/science.79019087901908Search in Google Scholar

8. M. C. Vogt and J. C. Brüning, CNS insulin signaling in the control of energy homeostasis and glucose metabolism – from embryo to old age, Trends Endocrinol. Metab. 24 (2013) 76–84; https://doi.org/10.1016/j.tem.2012.11.00410.1016/j.tem.2012.11.00423265947Search in Google Scholar

9. G. D. Calderon, N. Osnaya Brizuela, M. Ortiz Herrera, O. H. Juarez, A. Valenzuela Peraza and G. Barragan Mejía, Effect of an antiviral and vitamins A, C, D on dopamine and some oxidative stress markers in rat brain exposed to ozone, Arch. Biol. Sci. Belgrade65 (2013) 1371–1379; https://doi.org/10.1186/s12868-018-0474-410.1186/s12868-018-0474-4623023430413185Search in Google Scholar

10. D. Calderón Guzmán, N. Osnaya Brizuela, M. Ortíz Herrera, E. Hernandez Garcia, G. Barragan Mejía, H. Juarez Olguín, A. Valenzuela Peraza, J. Attilus and N. Labra Ruiz, Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid, Acta Pharm. 66 (2016) 443–448; https://doi.org/10.1515/acph-2016-002710.1515/acph-2016-002727383892Search in Google Scholar

11. F. Bilotta and G. Rosa, Optimal glycemic control in neurocritical care patients, Crit. Care16 (2012) 163–165; https://doi.org/10.1186/cc1152110.1186/cc11521368226423106972Search in Google Scholar

12. S. Ammon-Treiber, D. Stolze, H. Schroder, H. Loh and V. Hollt, Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model, Neuropharmacology49 (2005) 1160–1169; https://doi.org/10.1016/j.neuropharm.2005.06.01610.1016/j.neuropharm.2005.06.01616098996Search in Google Scholar

13. J. H. Jhamandas, K. H. Harris, T. Petrov and K. H. Jhamandas, Activation of nitric oxide-synthesizing neurons during precipitated morphine withdrawal, Neuroreport7 (1996) 2843–2846.10.1097/00001756-199611250-000069116193Search in Google Scholar

14. G. D. Calderón, G. E. Hernández, M. G. Barragán, O. H. Juárez, G. J. Saldivar and R. N. Labra, Effect of morphine and lacosamide on levels of dopamine and 5-HIAA in brain regions of rats with induced hypoglycemia, Pak. J. Biol. Sci. 17 (2014) 292–296.10.3923/pjbs.2014.292.29624783817Search in Google Scholar

15. S. P. Filippov, ATPase activity of rat brain microsomal and synaptosomal fractions in insulin hypoglycemia and its treatment with glucose, Probl. Endokrinol. (Moskow) 37 (1991) 52–54; https://doi.org/10.1134/S002209300602006210.1134/S0022093006020062Search in Google Scholar

16. E. Mandosi, E. Giannetta, T. Filardi, M. Lococo, C. Bertolini, M. FAllarino, D. Gianfrilli, M. A. Venneri, L. Lenti, S. Morano and A. Lenzi, Endothelial dysfuntion markers as a therapeutic target for sildenafil treatment and effects on metabolic control in type 2 diabetes, Expert Opin. Ther. Target. 19 (2015) 1617–1622; https://doi.org/10.1517/14728222.2015.106633710.1517/14728222.2015.106633726178526Search in Google Scholar

17. C. E. Ramirez, H. Nian, Y. Chang, L. J. Gamboa, J. M. Luther, N. J. Brown and C. A. Shibao, Treatment with sildenafil improves insulin sensitivity in prediabetes: a randomized, controlled trial, JCEM100 (2015) 4533–4540; https://doi.org/10.1210/jc.2015-341510.1210/jc.2015-3415466716326580240Search in Google Scholar

18. F. G. Al-Amran, A. A. Zwain, N. R. Hadi and A. M. Al-Mudhaffer, Autonomic cerebral vascular response to sildenafil in diabetic patient, Diabetol. Metab. Syndr.4 (2012) 2–8; https://doi.org/10.1186/1758-5996-4-210.1186/1758-5996-4-2329281822284589Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo